Welcome & Intro:
Roundtable Updates:
Discussion:
Next Steps:
Action Items & Closing Remarks:
Participants:
international_vaccine_codes_2023.12.13.pptx
Introduction Round:
Meeting Scope:
Meeting Schedule and Format:
Next Steps:
Meeting Conclusion:
Speaker: Nathan Bunker, AIRA
Paloma Hawry: Data Retrieval
Chris Sorenson, AIRA: Automation Process
Max Masnick (MITRE): Smart Health Cards
Code Set Update Process Presentation:
General Discussion:
international_vaccine_codes_2023.10.11.pptx
Participants
The call begin with introductions and short updates from the American Immunization Registry Association (AIRA) and SYstème d'Aide à la Decision Médicale (SYADEM). For the balance of the time the group went through the metrics documented on this website and discussed how they can be improved.
international_vaccine_codes_2023-09-20.pptx
Participants:
Nathan Bunker from AIRA chaired the meeting, which was designed to focus solely on the technical aspects of vaccine code sets. The session opened with an agenda setting, clearly stating that the discussion would not delve into policy or operational elements of software. Participants were given an opportunity to introduce themselves, their organizational affiliations, and the challenges they have been encountering with vaccine code sets. This context-setting was crucial for aligning the conversation that followed, ensuring that all attendees were on the same page.
2023_09_20_whodrug_global_eng.pdf
The spotlight then shifted to the WHODrug project, presented by Salvador Alvarado from UMC. He provided an in-depth outline, touching on the project's focus on standardizing terminology for vaccines and medicines. Alvarado went on to emphasize the project's real-world application, specifically its integration into systems used by the Pan American Health Organization for immunization data standardization in Latin America. He also gave background information about the Uppsala Monitoring Center's global work, setting the stage for the technical discussion that followed.
A comprehensive dialogue ensued about drug coding standards, particularly focusing on the structure and utility of the WHO Drug Global database. Questions ranged from the intricacies of drug code structures to the complexities involved in coding multivalent vaccines. Alvarado led the discussion, explaining how the codes are updated biannually and can be accessed in near real-time via an API. The conversation also elucidated the distinctions between WHO's drug codes and the IDMP (Identification of Medicinal Products) project, emphasizing the extent to which several regulatory agencies recommend or require these standards.
To conclude, Nathan Bunker highlighted ongoing work on developing metrics for vaccine code sets. The aim is to evaluate the capabilities of these sets in coding vaccines that are currently in use, have been used in the past, or are used globally. Bunker indicated that this information will be organized and made publicly available on a Wiki page, which will serve as a centralized resource for future discussions and evaluations.